You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-647-ESGO Real-word therapy and clinical and patient-reported outcomes in patients with newly diagnosed advanced ovarian cancer: first description of the SCOUT-1 study centers (NOGGO ov54, NCT04830709)

Article info

Article menu

Download PDFPDF

Ovarian cancer
2022-RA-647-ESGO Real-word therapy and clinical and patient-reported outcomes in patients with newly diagnosed advanced ovarian cancer: first description of the SCOUT-1 study centers (NOGGO ov54, NCT04830709)
Free

Authors

  • Jalid Sehouli Department of Gynaecology, European Competence Center for Ovarian Cancer, Campus Virchow-Klinikum, Charité Medical University, Berlin, Germany North-Eastern German Society of Gynecological Oncology (NOGGO), Berlin, Germany PubMed articlesGoogle scholar articles
  • Elena Ioana Braicu Department of Gynaecology, European Competence Center for Ovarian Cancer, Campus Virchow-Klinikum, Charité Medical University, Berlin, Germany North-Eastern German Society of Gynecological Oncology (NOGGO), Berlin, Germany PubMed articlesGoogle scholar articles
  • Regina Maria Glowik AstraZeneca, Hamburg, Germany PubMed articlesGoogle scholar articles
  • Klaus Pietzner Department of Gynaecology, European Competence Center for Ovarian Cancer, Campus Virchow-Klinikum, Charité Medical University, Berlin, Germany North-Eastern German Society of Gynecological Oncology (NOGGO), Berlin, Germany PubMed articlesGoogle scholar articles
  • Matthias Rose Centre for Internal Medicine and Dermatology, Department of Psychosomatic Medicine, Charité Medical University, Berlin, Germany PubMed articlesGoogle scholar articles
  • Pauline Wimberger Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany North-Eastern German Society of Gynecological Oncology (NOGGO), Berlin, Germany PubMed articlesGoogle scholar articles
  • Theresa Link Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles

Citation

Sehouli J, Braicu EI, Glowik RM, et al
2022-RA-647-ESGO Real-word therapy and clinical and patient-reported outcomes in patients with newly diagnosed advanced ovarian cancer: first description of the SCOUT-1 study centers (NOGGO ov54, NCT04830709)
International Journal of Gynecologic Cancer 2022;32:A250.

Publication history

  • First published October 20, 2022.
Online issue publication 
October 27, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.